0001179110-14-011449.txt : 20140703
0001179110-14-011449.hdr.sgml : 20140703
20140703142818
ACCESSION NUMBER: 0001179110-14-011449
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140701
FILED AS OF DATE: 20140703
DATE AS OF CHANGE: 20140703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARTIN JOHN C
CENTRAL INDEX KEY: 0001190578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 14960226
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DRIVE
CITY: FOSTER CITY
STATE: X1
ZIP: 94404
4
1
edgar.xml
FORM 4 -
X0306
4
2014-07-01
0
0000882095
GILEAD SCIENCES INC
GILD
0001190578
MARTIN JOHN C
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
1
0
0
Chairman and CEO
Common Stock
2014-07-01
4
M
0
140625
8.005
A
4570012
D
Common Stock
2014-07-01
4
S
0
30225
83.9555
D
4539787
D
Common Stock
2014-07-01
4
S
0
92300
85.0133
D
4447487
D
Common Stock
2014-07-01
4
S
0
18100
85.3966
D
4429387
D
Non-Qualified Stock option (right to buy)
8.005
2014-07-01
4
M
0
140625
0
D
2015-01-26
Common Stock
140625
703133
D
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
Sale prices reported for the transactions reported here range from $83.35 to $84.35. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Sale prices reported for the transactions reported here range from $84.36 to $85.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Sale prices reported for the transactions reported here range from $85.37 to $85.46. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
/s/ Brett A. Pletcher by Power of Attorney for John C. Martin
2014-07-03